✦ LIBER ✦

HIGH RISK OF VASCULAR EVENTS IN PATIENTS WITH UROTHELIAL TRANSITIONAL CELL CARCINOMA TREATED WITH CISPLATIN BASED CHEMOTHERAPY

✍ Scribed by CZAYKOWSKI, PIOTR M.; MOORE, MALCOLM J.; TANNOCK, IAN F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel with Cisplatin as Salvage Tre

✍ Uhm, Ji Eun; Lim, Ho Yeong; Kim, Won Seog; Choi, Han Yong; Lee, Hyun Moo; Park, 📂 Article 📅 2007 🏛 Neoplasia Press 🌐 English ⚖ 83 KB

Transitional cell carcinoma of the ovary

✍ D.M. Gershenson; E.G. Silva; M.F. Mitchell; E.N. Atkinson; J.T. Wharton 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Prospective evaluation of major vascular

✍ Gianmauro Numico; Ornella Garrone; Vincenzo Dongiovanni; Nicola Silvestris; Ida 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Prospective evaluation of major vascular

✍ Ramón Barceló; Alberto Muñoz; Guillermo López-Vivanco 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

Enterocolitis related to chemotherapy wi

✍ Y.J. YANG; J.S. LIM; H.J. LEE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Prospective Trial of Ifosfamide, Paclita

✍ Matthew D. Galsky; Alexia Iasonos; Svetlana Mironov; Joseph Scattergood; S. Mach 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 102 KB